摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

吗啉氢溴酸盐 | 6377-82-8

中文名称
吗啉氢溴酸盐
中文别名
——
英文名称
morpholinium bromide
英文别名
morpholine hydrobromide;morpholin-4-ium;bromide
吗啉氢溴酸盐化学式
CAS
6377-82-8
化学式
Br*C4H10NO
mdl
——
分子量
168.034
InChiKey
BVJOXYJFOYNQRB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    212 °C

计算性质

  • 辛醇/水分配系数(LogP):
    0.18
  • 重原子数:
    7
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    21.3
  • 氢给体数:
    2
  • 氢受体数:
    2

安全信息

  • 储存条件:
    存放于惰性气体中,并避免接触湿气(尤其是吸湿性的)。

SDS

SDS:798c029acc6ee7eff610c1755550f3b6
查看

反应信息

  • 作为反应物:
    描述:
    吗啉氢溴酸盐 在 HBr 、 H2O 作用下, 以 为溶剂, 生成
    参考文献:
    名称:
    Preparative and structural studies of halodimolybdates(II). VII. Synthesis and crystal structures of (morphH)2Mo2X6(H2O)2 (X = Cl, Br; morph = morpholine)
    摘要:
    DOI:
    10.1016/s0020-1693(00)86976-5
  • 作为产物:
    描述:
    吗啉氢溴酸 作用下, 以 乙醚 为溶剂, 反应 0.17h, 以86%的产率得到吗啉氢溴酸盐
    参考文献:
    名称:
    具有可调带隙的锡 (IV) 的金属 - 有机杂化物:吗啉六卤锡酸盐 (IV) 的合成、光谱、单晶 X 射线结构、BVS 和 CSM 分析
    摘要:
    摘要 以氯化吗啉 (1) 和溴化吗啉 (2) 在室温下合成了自组装有机-无机杂化材料,如吗啉六氯锡酸 (IV) (3) 和吗啉六溴代锡酸 (IV) (4)。通过元素分析、IR、NMR、TG-DTA、DRS和PL光谱以及单晶X射线衍射对杂化物进行了表征。(3) 和 (4) 的 IR 和 NMR 光谱数据与其母体化合物 (1) 和 (2) 相比几乎没有变化。然而,溴化物杂化物 (4) 的 = NH2+ 质子信号显示出相对较低的 δ 值,这是由于与其氯化物类似物 (3) 相比具有广泛的氢键。热分析证实了化合物的建议式。光吸收测量值显示为 3.80 和 2。(3) 和 (4) 在室温下的带隙分别为 60 eV,这意味着可以通过改变卤离子轻松调整带隙。化合物 (3) 和 (4) 的单晶 X 射线结构揭示了吗啉阳离子与 (3) 和 (4) 中的 SnCl62- 和 SnBr62- 阴离子之间存在广泛的氢键相互作用。在
    DOI:
    10.1016/j.molstruc.2020.128489
  • 作为试剂:
    描述:
    3-(Bromomethyl)-3-phenyldioxetane吗啉氢溴酸盐 作用下, 以 甲醇 为溶剂, 反应 0.17h, 生成 3-bromo-2-phenylpropane-1,2-diol 、 2,3-Dibromo-2-phenylpropyl hydroperoxide
    参考文献:
    名称:
    The SN2 Reactivity of 3,3-Disubstituted 1,2-Dioxetanes with Morpholine
    摘要:
    The reaction of morpholine with the 3-aryl-3-methyldioxetanes 1a-c (Y = 4-OMe, H, 4-NO2), the 3-(methoxymethyl)-3-phenyldioxetane (1d), and the 3-(halomethyl) 3-phenyldioxetanes 1e,f (X = Cl, Br) was investigated to determine the S(N)2 reactivity of these dioxetanes and the product distribution of the hydroxylamine ether 2 adducts and the dioxetane fragmentation products 3. It was shown that the overall rectivity and the product distribution are strongly dependent on the substituents of the dioxetanes 1. Thus, the reactivity of the dioxetanes 1 toward morpholine was demonstrated to correlate with the electron-accepting propensity of the substituents in the 3-position, while the product distribution depends on the electronic features of the primary dipolar adduct, which results from nucleophilic attack at the dioxetane peroxide bond. Electron-donating substituents (Y = 4-OMe) favor proton transfer from the hydroxylammonium site to the alkoxide ion due to the enhanced basicity of the latter, and, therefore, the formation of the hydroxylamine ether 2 is promoted. Additionally, electron-accepting substituents (Y = NO2) facilitate the Grob fragmentation of the primary dipolar adduct to the dioxetane cleavage products 3. The unexpected formation of the hydroperoxide 4f in the reaction of the dioxetane If with morpholine was shown to result from acid-catalyzed ring opening of the dioxetane by morpholinium bromide and subsequent morpholine trapping of the resulting stabilized, bromine-bridged benzylic cation.
    DOI:
    10.1021/jo00114a044
点击查看最新优质反应信息

文献信息

  • Biarylmethyl indolines, indoles and tetrahydroquinolines, useful as serine protease inhibitors
    申请人:——
    公开号:US20040220206A1
    公开(公告)日:2004-11-04
    The present invention provides compounds of Formula (I): 1 or a stereoisomer or pharmaceutically acceptable salt or hydrate form thereof, wherein the variables A, B, L 1 , L 2 , X 1 , X 2 , X 3 , X 4 and W are as defined herein. The compounds of Formula (I) are useful as selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; for example thrombin, factor Xa, factor XIa, factor IXa, factor VIIa and/or plasma kallikrein. In particular, it relates to compounds that are selective factor XIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
    本发明提供了Formula (I)的化合物:1或其立体异构体或药用可接受的盐或合物形式,其中变量A、B、L1、L2、X1、X2、X3、X4和W如本文所定义。Formula (I)的化合物可作为凝血级联和/或接触激活系统的丝氨酸蛋白酶酶的选择性抑制剂,例如凝血酶、因子Xa、因子XIa、因子IXa、因子VIIa和/或血浆激肽。具体地,涉及具有选择性因子XIa抑制剂的化合物。本发明还涉及包含这些化合物的药物组合物以及使用这些药物组合物治疗血栓栓塞性和/或炎症性疾病的方法。
  • Functionalized enamines—XXXII
    作者:C.B. Kanner、U.K. Pandit
    DOI:10.1016/0040-4020(82)80066-5
    日期:1982.1
    benzyl bromide 2 and cinnamyl bromide 3 give products which are dependent both upon the nature of the amine component of the enamine and, in the case of the amides, upon the amine from which the amide is derived. The β-enamino esters react with benzyl bromide to yield predominantly dialkylated products in the case of the pyrrolidine ester 1a. Reactions of the same esters with cinnamyl bromide yield
    β-丙烯酸酯(1-c)和酰胺(1d-o)与苄基2和肉桂基溴3的反应生成的产物既取决于烯胺的胺成分的性质,又取决于酰胺,从中衍生出酰胺的胺上。在吡咯烷酯1a的情况下,β-烯基酯与苄基反应,主要产生二烷基化产物。相同的酯与肉桂基溴的反应产生肉桂基和2-苯基丙烯基取代的甲酰基乙酸酯的混合物。烯基酰胺1d–f反应生成预期的烷基化衍生物苯胺1i–o在苯胺氮上表现出亲核反应性。提出了导致观察到的产物的机制。
  • Two halide exchange in copper(II) halide dimers: (Morpholinium)2Cu2ClxBr6−x
    作者:Roger D. Willett、Robert Butcher、Christopher P. Landee、Brendan Twamley
    DOI:10.1016/j.poly.2005.03.121
    日期:2005.11
    the morpholinium cations to the copper ions via semi-coordinate Cu⋯O bonds. This is in contrast to other such dimer systems, where semi-coordinate Cu⋯X bonds link the dimers together into stacks or chains. In the morpholinium salts, hydrogen bonding ties the molecular units into a layered structure. These N–H⋯X hydrogen bonds force short X⋯X contacts between dimers with X⋯X distances of 3.92–4.07 A
    摘要研究了(吗啉)2 Cu 2 Cl 6-xBrx盐中平面Cu 2 Cl 6-x Br x 2-二聚体的结构和磁性。Cu 2 Cl 6 2-盐为三斜晶系,空间群P 1,a = 7.408(7),b = 10.458(10),c = 11.933(12)A,α= 82.26(2),β= 88.35( 2),γ= 77.22(2)°,Z = 2,而Cu 2 Br 6 2-盐是单斜晶的,空间群P21 / c,a = 14.148(6),b = 10.814(4),c = 14.298(6)A和β= 117.108(7)°,Z =4。混合的卤化物盐与Cu 2 Br 6 2-盐都是同构的。在结构上,由于吗啉阳离子通过半配位的Cu⋯O键与离子的配位较弱,因此这些化合物包含分离的二聚体。这与其他这样的二聚体系统相反,在其他二聚体系统中,半配位的Cu⋯X键将二聚体连接在一起成为堆叠或链状。在吗啉盐中,氢
  • 13 C CP MAS NMR, FTIR, X-ray diffraction and PM3 studies of some N -(ω-carboxyalkyl)morpholine hydrohalides
    作者:Z. Dega-Szafran、I. Gąszczyk、D. Maciejewska、M. Szafran、E. Tykarska、I. Wawer
    DOI:10.1016/s0022-2860(00)00754-7
    日期:2001.1
    centrosymmetric dimer, connected by two N + –H⋯Cl − (3.095(1) A) and two O–H⋯Cl − (3.003(1) A) hydrogen bonds. 13 C CP MAS NMR spectra, contrary to the solution, showed non-equivalence of the ring carbon atoms. The PM3 calculations predict a molecular dimer without proton transfer for an HCl complex, while for an HBr complex an ion pairs with proton transfer, and reproduces correctly the conformation of both
    摘要 N -(ω-羧基烷基)吗啉盐酸盐, OC 4 H 8 N(CH 2 ) n COOH·HCl, n = 1–5, 被 13 C 交叉极化 (CP) 魔角旋转 (MAS) NMR 分析, FTIR 和 PM3 计算。N-(3-羧丙基)吗啉盐酸盐(n = 3)的结构已通过X射线衍射法在100 K下解析并精制至R = 0.031。晶体为单斜晶系,空间群 P 2 1 / c , a =14.307(3), b =9.879(2), c=7.166(1) A , β =93.20(3)°, V=1011.3(3) A 3,Z=4。在该化合物中,氮原子被质子化,两个分子形成中心对称二聚体,由两个 N + –H⋯Cl − (3.095(1) A) 和两个 O–H⋯Cl − (3.003(1) A) 氢键连接. 与溶液相反,13 C CP MAS NMR 谱显示环碳原子不等价。PM3 计算预测 HCl
  • Rearrangement in the systems ethyl bromopyruvate-1-(cyclohex-1-enyl)piperidine, -pyrrolidine, and -morpholine as an effi cient approach to 4,5,6,7-tetrahydroindoles
    作者:V. A. Mamedov、A. I. Zamaletdinova、V. V. Syakaev、E. A. Khafizova、Sh. K. Latypov、O. G. Sinyashin
    DOI:10.1007/s11172-019-2512-5
    日期:2019.5
    Abstract1-(Cyclohex-1-enyl)piperidine, -pyrrolidine, and -morpholine react with ethyl bromopyruvate in refluxing dioxane to afford the corresponding 4,5,6,7-tetrahydroindole derivatives. Possibility to convert the synthesized compounds into their aromatic counterparts was exemplified by one model compound.
    摘要1-(Cyclohex-1-enyl)哌啶、-吡咯烷和-吗啉与丙酮酸乙酯在回流的二恶烷中反应,得到相应的4,5,6,7-四氢吲哚生物。一种模型化合物举例说明了将合成化合物转化为其芳族化合物的可能性。
查看更多